Edition:
United Kingdom

Otonomy Inc (OTIC.OQ)

OTIC.OQ on NASDAQ Stock Exchange Global Select Market

2.60USD
19 Oct 2018
Change (% chg)

$0.01 (+0.39%)
Prev Close
$2.59
Open
$2.56
Day's High
$2.66
Day's Low
$2.56
Volume
2,831
Avg. Vol
52,236
52-wk High
$6.40
52-wk Low
$2.21

Chart for

About

Otonomy, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Company's product candidates include OTIPRIO, OTO-104 and OTO-311. OTIPRIO is a single-dose, physician-administered antibacterial, which is used for the treatment... (more)

Overall

Beta: --
Market Cap(Mil.): $104.55
Shares Outstanding(Mil.): 30.30
Dividend: --
Yield (%): --

Financials

  OTIC.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -3.46 -- --
ROI: -53.30 0.21 14.27
ROE: -53.63 1.17 15.99

BRIEF-Otonomy Qtrly Loss Per Share $0.37

* OTONOMY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

09 May 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF87.04 +1.16

Earnings vs. Estimates